All Articles

As institutional capital slows, mega-funds turn to independent advisors. Tech platforms like CAIS are building the pipes for this trillion-dollar pivot.

By opening its 13th showroom in affluent Marin County, custom rug disruptor Ernesta proves that high-ticket DTC brands still need physical retail to scale.

As cheap capital vanishes, private equity firms are deploying veteran, on-demand CFOs to drive operational rigor and salvage value creation plans.

As AI and privacy laws kill third-party cookies, Meta's open-source MMM pioneer Gufeng Zhou joins Fospha to bring real-time measurement to the enterprise.

Ahead of a critical 2027 data readout, Moleculin pitches a breakthrough leukemia drug while navigating a precarious financial runway.

By appointing veteran sales and marketing leaders, SIOS Technology is telegraphing a major push to capture the booming hybrid cloud resilience market.

As the EU AI Act takes effect, a recent award in Jakarta highlights the urgent shift from experimental AI to tightly governed, secure enterprise infrastructure.

BookingCentral’s new AI Connector lets rental operators query their fleet and customer data in plain English, bypassing complex dashboards and spreadsheets.

Castle Connolly's new partnership with rater8 reveals a stark reality for 2026: clinical excellence means little if AI algorithms can't find your practice.

As Hampton Farms expands its postseason football footprint, we examine the strategic and economic impact of middle-market brand sponsorships in Nashville.

As the U.S. wine market faces historic contractions, Cavit's innovative partnership with Mike's Hot Honey offers a masterclass in institutional adaptation.

With the launch of Playground and the upcoming Unity Spark, Google and Unity are turning generative AI into the next frontier of interactive entertainment.

As electronic warfare severs cloud connectivity, Reveal Technology's offline 3D mapping software provides a glimpse into the future of infantry combat.

Shake Shack's upcoming Brazilian expansion reveals a calculated asset-light strategy, leveraging Bold Hospitality to navigate Latin America's complex market.

AmyriAD Therapeutics is betting an all-stock deal can turn a missed Phase 2b endpoint into a breakthrough for cognitive impairment in schizophrenia.

Joyride Dogs has surpassed $300,000 in rescue donations. Discover how embedding philanthropy into a DTC business model drives growth and builds brand loyalty.

A newly expanded partnership between ALZpath and Quanterix signals a massive shift in neurology, replacing costly PET scans with scalable blood-based biomarkers.

By weaponizing workplace culture and top-tier benefits, Tampa-based PainTEQ is securing the talent needed to dominate the booming SI joint fusion market.

After years of unchecked AI experimentation, a new partnership between DoiT and OpenAI signals a financial reckoning for enterprise generative AI on AWS.

Bright Path Labs is using military-backed continuous-flow technology to reshore critical drug manufacturing, challenging the dominance of overseas APIs.